We have located links that may give you full text access.
Model-based analysis of microbial consortia and microbial products in an anammox biofilm reactor.
A mathematical model for a granular biofilm reactor for leachate treatment was validated by long-term measured data to investigate the mechanisms and drivers influencing biological nitrogen removal and microbial consortia dynamics. The proposed model, based on Activated Sludge Model (ASM1), included anaerobic ammonium oxidation (anammox), nitrifying and heterotrophic denitrifying bacteria which can attach and grow on granular activated carbon (GAC) particles. Two kinetic descriptions for the model were proposed: with and without soluble microbial products (SMP) and extracellular polymeric substance (EPS). The model accuracy was checked using recorded total inorganic nitrogen concentrations in the effluent and estimated relative abundance of active bacteria using quantitative fluorescence in-situ hybridization (qFISH). Results suggested that the model with EPS kinetics fits better for the relative abundance of anammox bacteria and nitrifying bacteria compared to the model without EPS. The model with EPS and SMP confirms that the growth and existence of heterotrophs in anammox biofilm systems slightly increased due to including the kinetics of SMP production in the model. During the one-year simulation period, the fractions of autotrophs and EPS in the biomass were almost stable but the fraction of heterotrophs decreased which is correlated with the reduction in nitrogen surface loading on the biofilm.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app